TickerLeague

EPS (Diluted) for Viatris (VTRS)

According to Viatris's latest reported financial statements, the company's current diluted EPS (TTM) is $-2.96. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$-2.96

YoY change

+466.0%

5Y CAGR

N/A

Peak year (2014)

$2.34

Latest annual

$-3.00

EPS (Diluted) history chart for Viatris (VTRS) from 2003 to 2025

EPS (Diluted) history table for Viatris (VTRS) from 2003 to 2025

Fiscal yearPeriod endedReportedEPS (Diluted)YoY
2025$-3.00+466.0%
2024$-0.53-1270.0%
2023$0.05-97.4%
2022$1.71-262.9%
2021$-1.05-5.4%
2020$-1.11-3800.0%
2019$0.03-95.6%
2018$0.68-47.7%
2017$1.30+41.3%
2016$0.92-45.9%
2015$1.70-27.4%
2014$2.34+48.1%
2013$1.58+3.9%
2012$1.52+24.6%
2011$1.22+79.4%
2010$0.68+126.7%
2009$0.30-146.9%
2008$-0.64-89.2%
2007$-5.90
2005$0.79+6.8%
2004$0.74-38.8%
2003$1.21

EPS (Diluted) values are taken from Viatris's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Viatris (VTRS) reported diluted EPS of $-3.00 – surged 466.0% year-over-year.

Viatris diluted EPS plunged from $2.34 in 2014 to $-3.00 in 2025, a 228.2% drawdown.

The highest annual diluted EPS of $2.34 was reported in 2014. The lowest in the available history was $-5.90 in 2007.

Among 8 Healthcare peers, Viatris (VTRS) ranks 9th; the peer median for diluted EPS is $13.16.

Viatris EPS (Diluted) by Year

Viatris EPS (Diluted) 2025: $-3.00

Viatris diluted EPS in 2025 was $-3.00, surged 466.0% from 2024.

Viatris EPS (Diluted) 2024: $-0.53

Viatris diluted EPS in 2024 was $-0.53, plunged 1270.0% below 2023.

Viatris EPS (Diluted) 2023: $0.05

Viatris diluted EPS in 2023 was $0.05, plunged 97.4% below 2022.

Viatris EPS (Diluted) 2022: $1.71

Viatris diluted EPS in 2022 was $1.71, plunged 262.9% below 2021.

Viatris EPS (Diluted) 2021: $-1.05

Viatris diluted EPS in 2021 was $-1.05.

See more financial history for Viatris (VTRS).

Sector peers — EPS (Diluted)

Companies in the same sector as Viatris, ranked by their latest diluted EPS.

CompanyEPS (Diluted)Sector
Novo Nordisk A/S (NVO)$23.03Healthcare
Eli Lilly and Company (LLY)$22.95Healthcare
Amgen Inc. (AMGN)$14.23Healthcare
UnitedHealth Group Incorporated (UNH)$13.23Healthcare
AstraZeneca PLC (AZN)$13.08Healthcare
Johnson & Johnson (JNJ)$11.03Healthcare
Merck & Co., Inc. (MRK)$7.28Healthcare
AbbVie Inc. (ABBV)$2.37Healthcare

Frequently asked questions

What is Viatris's diluted EPS?

Latest reported diluted EPS for Viatris (VTRS) is $-2.96 (period ending December 31, 2025).

How has Viatris diluted EPS changed year-over-year?

Viatris (VTRS) diluted EPS changed +466.0% year-over-year on the latest annual filing.

When did Viatris diluted EPS hit its highest annual value?

Viatris diluted EPS reached its highest annual value of $2.34 in 2014.

What was Viatris diluted EPS in 2024?

Viatris (VTRS) diluted EPS in 2024 was $-0.53.

What was Viatris diluted EPS in 2025?

Viatris (VTRS) diluted EPS in 2025 was $-3.00.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.